Abstract: A method, system and computer program product for improving the understanding of chat transcript data. Chat transcripts are analyzed to classify the utterances into intents and identify products discussed in the chat transcripts. The data of the chat transcripts are divided into categories of utterances associated with products and intents by applying tags to the chat transcripts. The categories of utterances associated with products and intents are then clustered into clusters based on sentence similarity. Once the utterances are grouped, a representative utterance is extracted from a cluster, where the representative utterance is an utterance that has the highest semantic similarity to the utterances in the cluster. In this manner, users will be provided a more accurate guide as to the underlying meaning of the chat transcript data thereby improving the understanding of the chat transcript data more efficiently and accurately than current chat transcript analysis tools.

Abstract: A method, system and computer program product for improving the understanding of chat transcript data. Chat transcripts are analyzed to classify the utterances into intents and identify products discussed in the chat transcripts. The data of the chat transcripts are divided into categories of utterances associated with products and intents by applying tags to the chat transcripts. The categories of utterances associated with products and intents are then clustered into clusters based on sentence similarity. Once the utterances are grouped, a representative utterance is extracted from a cluster, where the representative utterance is an utterance that has the highest semantic similarity to the utterances in the cluster. In this manner, users will be provided a more accurate guide as to the underlying meaning of the chat transcript data thereby improving the understanding of the chat transcript data more efficiently and accurately than current chat transcript analysis tools.

Abstract: This invention provides novel inhibitors of the enzyme D-amino acid oxidase as well as pharmaceutical compositions including the compounds of the invention. The invention also provides methods for the treatment and prevention of neurological disorders, such as neuropsychiatric and neurodegenerative diseases, as well as pain, ataxia and convulsion. The compounds of the invention have the general structure: wherein A is NH or S. Q is a member selected from CR1 and N. X and Y are members independently selected from O, S, CR2, N and NH. R1, R2 and R4 are members independently selected from H and F, provided that at least one member selected from R1, R2 and R4 is F. R6 is a member selected from O?X+ and OH, wherein X+ is a positive ion, which is a member selected from inorganic positive ions and organic positive ions.

Abstract: The invention encompasses methods of using racemic and enantiomerically pure norfluoxetine, as well as pharmaceutical compositions, pharmaceutical unit dosage forms, and kits comprising racemic and enantiomerically pure norfluoxetine. In particular, the invention encompasses a method of inhibiting or reducing the production of PGE2. The invention further encompasses a method of treating or preventing inflammation in a patient, as well as a method of treating or preventing a disease or disorder such as, but not limited to, autoimmune diseases, arthritis, neurologic diseases, inflammatory diseases, fibromyalgia, pain resulting from inflammation, neuropathic pain, and cancer.

Abstract: The invention encompasses methods of using racemic and enantiomerically pure norfluoxetine, as well as pharmaceutical compositions, pharmaceutical unit dosage forms, and kits comprising racemic and enantiomerically pure norfluoxetine. In particular, the invention encompasses a method of inhibiting or reducing the production of PGE2. The invention further encompasses a method of treating or preventing inflammation in a patient, as well as a method of treating or preventing a disease or disorder such as, but not limited to, autoimmune diseases, arthritis, neurologic diseases, inflammatory diseases, fibromyalgia, pain resulting from inflammation, neuropathic pain, and cancer.

Abstract: A pad lock mechanism is described having a body portion and a latch which cooperate to lock and unlock the device. The body portion has at least one body core and a biasing element disposed within the body core for biasing or displacing the latch a predetermined depth therein. The body core includes a locking mechanism and at least two channels for insertably receiving a latch. The lock mechanism is unlocked via a multipurpose key element which is configured to operate via a single handcuff key which alleviates worry associated with trying to find a single key from a ring having numerous keys thereon. The lock mechanism utilizes a simple T-shaped structure which forms a locking arrangement via single and dual recess latch configurations. The lock is made from a durable metal material which is impervious to rust and corrosion.

Abstract: A power failure scheme for a gaming device in which, upon the detection of a failure of the line power, particular processing operations are completed before power is completely lost. A regulated D.C. power supply coupled to the line power generates an interrupt having the highest priority upon detecting a failure of the line power. The main processor of the gaming device is responsive to a power fail interrupt to complete any access to a safe memory which may have been on-going at the time the interrupt was generated or to complete any state transition which was on-going at the time the interrupt was generated.